Loading…
Loading…
Zoetis Inc - Class A
NYSE · Stock Profile · Market Cap $51.72B
Current Price
$117.35
-3.56%GoodMoat Value
$137.50
17.2% undervaluedEarnings per share grew at a 35.4% CAGR.
Forward estimates use 35.4% FCF growth (CAGR)
Net Debt: 6.9B
2.4B
FY24
2.4B
FY24
9.3B
FY24
2.2B
FY25
2.5B
FY25
2.4B
FY25
9.5B
FY25
624M
FY24
682M
FY24
2.5B
FY24
631M
FY25
718M
FY25
721M
FY25
2.7B
FY25
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock producers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $9.3 billion in 2024 with approximately 13,800 employees.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NYSE
Country
New Jersey, USA
Earnings per share grew at a 35.4% CAGR.
Blended fair value estimate based on DCF, Graham Number, and earnings-based models.
Run a full DCF analysis with customizable assumptions
Open DCF Calculator →Graham Number, PEG-based, and Earnings-based models
View Fair Value →Dividend Yield
1.71%
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock producers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $9.3 billion in 2024 with approximately 13,800 employees.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NYSE
Country
New Jersey, USA